Accelerating the Development of Veterinary Breakthroughs
NEWS: IMULAN receives American Kennel Club (AKC) - Canine Health Foundation grant to develop diagnostic for canine atopic dermatitis (atopy); <<read more>>
Canine Studies
Valley Fever (CLOSED)
Dilated Cardiomyopathy (CLOSED) Press Release 05.12.09
Atopic Dermatitis (starting)
Available Abstract
Atopic Dermatitis Diagnostic (in house, initiated) Press Release
Parvovirus (CLOSED)
Feline Studies
Feline Infectious Peritonitis (Contact IMULAN for Availability)
Feline Leukemia Virus (Contact IMULAN for Availability)
FeLV & FIV Diagnostic Trial (Contact IMULAN for Availability)
Feline Stomatitis (starting)
Cancer (Oncology)
Lymphoma (Contact IMULAN for Availability)
apSTAR Cancer Laser; visit Veterinary Cancer Therapeutics, LLC
IMULAN solves complex veterinary diseases by developing breakthrough therapeutic strategies and by working with progressive veterinarians around the country. Our expert clinical development team has identified a new therapeutic generation of products that propose to overcome the deficits of traditional drug therapy. We are accelerating product development by focusing only on the most promising technologies and removing the bureaucracy of traditional drug development companies.
This site provides information about our current clinical development program in feline and canine medicine.
IMULAN BioTherapeutics - Clinical Trials
1042 Willow Creek Rd; A101-430
Prescott, AZ 86301 USA
www.IMULAN.com
The study programs are investigational in nature and conducted only by licensed and qualified veterinarians. The investigational biologics used are not available for sale or commercial use for these diseases. Studies are conducted in accordance with standard regulatory policies and guidelines